Picture of Terrascend logo

TSND — Terrascend News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapContrarian

Brief: Medipharm Labs, TerrAscend Enter Into Label Concentrate Supply Agreement

Sept 25 (Reuters) - Medipharm Labs Corp  LABS.TO :
    * MEDIPHARM LABS - TERRASCEND WILL HAVE OPTION TO PURCHASE
UP TO
ADDITIONAL $105 MILLION OF CANNABIS CONCENTRATE OVER SAME
PERIOD, IN DEAL
    * MEDIPHARM LABS - DEAL HAS OPTION FOR 12 MONTH MUTUAL
EXTENSION
WHERE IF EXTENDED TERRASCEND WOULD BUY AT LEAST ABOUT $10
MILLION CANNABIS CONCENTRATE
    * MEDIPHARM LABS AND TERRASCEND ENTER MAJOR PRIVATE LABEL
CONCENTRATE SUPPLY AGREEMENT WITH POTENTIAL VALUE UP TO $192
MILLION
    * MEDIPHARM LABS - WILL SUPPLY TERRASCEND WITH ABOUT $27
MILLION
OF PRIVATE LABEL CANNABIS DISTILLATE, OVER 24-MONTHS COMMENCING
SEPT
    * MEDIPHARM LABS CORP - MULTI-YEAR SUPPLY AGREEMENT TO
SUPPORT
TERRASCEND'S ROLL OUT OF CANADIAN CANNABIS 2.0 DERIVATIVE
PRODUCTS

Source text: https://reut.rs/2n2bM1Z
Further company coverage:  LABS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Terrascend

See all news